ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1091

Risk of Preterm Birth by Timing of Lupus Diagnosis Among Women in the Georgia Lupus Registry

Meghan Angley1, Penelope P. Howards 1, Cristina Drenkard 1 and S Sam Lim 1, 1Emory University, Atlanta, GA

Meeting: 2019 ACR/ARP Annual Meeting

Keywords: pregnancy and Reproductive Health, Systemic lupus erythematosus (SLE)

  • Tweet
  • Email
  • Print
Session Information

Date: Monday, November 11, 2019

Title: Epidemiology & Public Health Poster II: Spondyloarthritis & Connective Tissue Disease

Session Type: Poster Session (Monday)

Session Time: 9:00AM-11:00AM

Background/Purpose: Women with systemic lupus erythematosus (SLE) are at a greater risk of having a preterm birth than the general population. Most studies examine preterm births in women with SLE only after they have been diagnosed with SLE, but it has been established that both symptoms and immune abnormalities can appear years before a clinical diagnosis of SLE is made.

Methods: The Georgia Lupus Registry (GLR) is a population-based registry of individuals with SLE in 2002-2004 in Atlanta, Georgia. The GLR was matched to Georgia Birth Certificates from 1994-2013. Births were categorized by timing before and after diagnosis (≥3 years before, 0-3 years before, 0-3 years after and ≥3 years after). Risks of preterm birth (delivery < 37 weeks of gestation) were calculated. Log-risk models with generalized estimating equations accounted for multiple deliveries in the same woman. Only singleton births were analyzed.

Results: In 189 women, 297 singleton births were identified; 80% were to African American and 18% to white women, and 125 births occurred before and 172 births occurred after diagnosis (see figure 1). For births occurring ≥3 years before, 0-3 years before, 0-3 years after and ≥3 years after, the risks of preterm birth were 19%, 29%, 34% and 33%, respectively. Compared to women who gave birth ≥3 years before, women who gave birth 0-3 years before had slightly elevated risk of preterm birth (risk ratio [RR]: 1.46, 95% confidence interval [CI]: 0.79, 2.68), as did women who gave birth 0-3 years after (RR: 1.64, 95% CI: 0.89, 3.04) and women who gave birth ≥3 years after (RR: 1.53, 95% CI: 0.89, 2.62) (see figure 2). Analyses controlled for parity, age and race.

Conclusion: The risk of preterm birth is also increased preceding SLE diagnosis, although lower than that after diagnosis. This suggests late diagnosis of SLE or that immunologic and other factors may impact birth outcomes years before clinical disease.


ACR_Figure1

Figure 1. Distribution of births by timing of SLE diagnosis


ACR_Figure2

Figure 2. Adjusted risk ratio of preterm birth by timing of SLE diagnosis, compared to births occurring 3+ years before SLE diagnosis


Disclosure: M. Angley, None; P. Howards, None; C. Drenkard, None; S. Lim, None.

To cite this abstract in AMA style:

Angley M, Howards P, Drenkard C, Lim S. Risk of Preterm Birth by Timing of Lupus Diagnosis Among Women in the Georgia Lupus Registry [abstract]. Arthritis Rheumatol. 2019; 71 (suppl 10). https://acrabstracts.org/abstract/risk-of-preterm-birth-by-timing-of-lupus-diagnosis-among-women-in-the-georgia-lupus-registry/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2019 ACR/ARP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/risk-of-preterm-birth-by-timing-of-lupus-diagnosis-among-women-in-the-georgia-lupus-registry/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology